Variable | Total (n=126) | NEU (n=24) | EP (n=26) | LVIS/LVIS Jr. (n=76) | P value |
Age, years±SD | 54.1±12.7 | 56.2±10.9 | 55.0±10.9 | 53.2±13.8 | 0.565 |
Sex, n/N (%) | |||||
Female | 81 (64) | 14 (58) | 20 (77) | 47 (62) | 0.323 |
Male | 45 (36) | 10 (42) | 6 (23) | 29 (38) | |
Location, n/N (%) | |||||
Anterior circulation | 85/125 (68) | 11 (46) | 13 (50) | 61/75 (81) | <0.001 |
Posterior circulation | 40/125 (32) | 13 (54) | 13 (50) | 14/75 (19) | |
Size (mm), n/N (%) | |||||
Small (″5) | 52/125 (42) | 8 (33) | 11 (42) | 33/75 (44) | 0.35 |
Medium (>5–<15) | 65/125 (52) | 16 (67) | 12 (46) | 37/75 (49) | |
Large (≥15–<25) | 7/125 (6) | 0 (0) | 2 (8) | 5/75 (7) | |
Giant (≥25) | 1/125 (1) | 0 (0) | 1 (4) | 0 (0) | |
Wide neck, n/N (%) | |||||
No | 7/122 (6) | 3/23 (13) | 1/24 (4) | 3/75 (4) | 0.237 |
Yes | 115/122 (94) | 20/23 (87) | 23/24 (96) | 72/75 (96) | |
Side, n/N (%) | |||||
Right | 38/121 (31) | 10/21 (48) | 9/25 (36) | 19/75 (25) | 0.004 |
Left | 33/121 (27) | 5/21 (24) | 12/25 (48) | 16/75 (21) | |
Midline | 50/121 (41) | 6/21 (28) | 4/25 (16) | 40/75 (53) | |
Multiple aneurysms, n/N (%) | |||||
No | 124 (98) | 24 (100) | 24 (92) | 76 (100) | 0.076 |
Yes | 2 (2) | 0 (0) | 2 (8) | 0 (0) | |
Stent configuration, n/N (%) | |||||
Single | 92/119 (77) | 19/21 (90) | 22/24 (92) | 51/74 (69) | <0.001 |
Y-stent | 21/119 (18) | 0 (0) | 0 (0) | 21/74 (28) | |
Telescope | 6/119 (5) | 2/21 (10) | 2/24 (8) | 2/74 (3) | |
Stent-coil technique, n/N (%) | |||||
Jailing | 54/120 (45) | 4/21 (19) | 13/24 (54) | 37/75 (49) | 0.027 |
Coil-through | 39/120 (32) | 7/21 (33) | 5/24 (21) | 27/75 (36) | |
Coil-stent | 14/120 (12) | 5/21 (24) | 3/24 (12) | 6/75 (8) | |
Balloon-stent | 13/120 (11) | 5/21 (24) | 3/24 (12) | 5/75 (7) | |
Occlusion, baseline, n/N (%) | |||||
RRGS I | 81/120 (68) | 11/21 (52) | 10/24 (42) | 60/75 (80) | <0.001 |
RRGS II | 24/120 (20) | 4/21 (19) | 7/24 (29) | 13/75 (17) | |
RRGS III | 15/120 (12) | 6/21 (29) | 7/24 (29) | 2/75 (3) | |
Occlusion, follow-up, n/N (%) | |||||
RRGS I | 84/109 (77) | 12/19 (63) | 11/19 (58) | 61/71 (86) | 0.018 |
RRGS II | 10/109 (9) | 2/19 (10) | 3/19 (16) | 5/71 (7) | |
RRGS III | 15/109 (14) | 5/19 (26) | 5/19 (26) | 5/71 (7) | |
Procedure-related complications | |||||
Rupture | 4 (3) | 1 (4) | 0 (0) | 3 (4) | 0.119 |
Stent thrombosis | 5 (4) | 1 (4) | 2 (8) | 2 (3) | |
Stroke | 3 (2) | 2 (8) | 1 (4) | 0 (0) | |
No complications | 114 (90) | 20 (83) | 23 (88) | 71 (93) | |
Post-procedural complications | |||||
Recurrence | 10 (8) | 4 (17) | 1 (4) | 5 (7) | 0.163 |
Stroke | 5 (4) | 1 (4) | 1 (4) | 3 (4) | |
Recurrence, stroke | 1 (1) | 1 (4) | 0 (0) | 0 (0) | |
Recurrence, stent stenosis | 1 (1) | 0 (0) | 1 (4) | 0 (0) | |
No complications | 109 (86) | 18 (75) | 23 (88) | 68 (89) |
EP, Enterprise; LVIS, Low-profile Visualized Intraluminal Support; NEU, Neuroform; RRGS, Raymond–Roy Grade Scale.